Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 22% ± 6% | |
epithelial cell | 6 studies | 29% ± 8% | |
fibroblast | 5 studies | 19% ± 1% | |
oligodendrocyte | 5 studies | 21% ± 3% | |
ciliated cell | 4 studies | 22% ± 5% | |
astrocyte | 4 studies | 23% ± 5% | |
natural killer cell | 3 studies | 20% ± 3% | |
B cell | 3 studies | 17% ± 1% | |
CD8-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
lymphocyte | 3 studies | 20% ± 3% | |
hepatocyte | 3 studies | 44% ± 20% | |
GABAergic neuron | 3 studies | 42% ± 9% | |
glutamatergic neuron | 3 studies | 48% ± 10% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 5% | |
basal cell | 3 studies | 23% ± 2% | |
transit amplifying cell | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4163.16 | 1445 / 1445 | 100% | 63.81 | 183 / 183 |
lung | 100% | 5248.35 | 578 / 578 | 100% | 49.68 | 1155 / 1155 |
ovary | 100% | 3701.89 | 180 / 180 | 100% | 27.71 | 429 / 430 |
prostate | 100% | 4608.37 | 244 / 245 | 100% | 50.48 | 501 / 502 |
thymus | 100% | 5509.48 | 653 / 653 | 99% | 32.54 | 599 / 605 |
bladder | 100% | 5070.52 | 21 / 21 | 99% | 37.40 | 499 / 504 |
uterus | 100% | 5344.07 | 170 / 170 | 99% | 34.20 | 454 / 459 |
intestine | 100% | 5078.98 | 966 / 966 | 98% | 44.31 | 519 / 527 |
liver | 100% | 4797.66 | 226 / 226 | 98% | 25.36 | 399 / 406 |
stomach | 100% | 4416.46 | 359 / 359 | 98% | 49.49 | 281 / 286 |
kidney | 100% | 3376.47 | 89 / 89 | 98% | 40.66 | 885 / 901 |
pancreas | 100% | 2812.96 | 327 / 328 | 98% | 46.63 | 175 / 178 |
adrenal gland | 100% | 3604.30 | 258 / 258 | 97% | 22.29 | 224 / 230 |
breast | 100% | 6828.74 | 459 / 459 | 97% | 33.01 | 1088 / 1118 |
brain | 95% | 1955.38 | 2518 / 2642 | 99% | 22.43 | 701 / 705 |
skin | 100% | 4745.15 | 1809 / 1809 | 91% | 25.24 | 430 / 472 |
adipose | 100% | 7212.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6557.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4449.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.63 | 1 / 1 |
muscle | 99% | 2410.08 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2437.57 | 845 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 20.76 | 28 / 29 |
peripheral blood | 89% | 2481.46 | 826 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 51% | 7.62 | 41 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097009 | Biological process | energy homeostasis |
GO_1904428 | Biological process | negative regulation of tubulin deacetylation |
GO_1905691 | Biological process | lipid droplet disassembly |
GO_0061762 | Biological process | CAMKK-AMPK signaling cascade |
GO_0010332 | Biological process | response to gamma radiation |
GO_0060627 | Biological process | regulation of vesicle-mediated transport |
GO_0009411 | Biological process | response to UV |
GO_0014823 | Biological process | response to activity |
GO_2000758 | Biological process | positive regulation of peptidyl-lysine acetylation |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0006914 | Biological process | autophagy |
GO_0006468 | Biological process | protein phosphorylation |
GO_0031000 | Biological process | response to caffeine |
GO_0048511 | Biological process | rhythmic process |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0006006 | Biological process | glucose metabolic process |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0071417 | Biological process | cellular response to organonitrogen compound |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0009631 | Biological process | cold acclimation |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0033135 | Biological process | regulation of peptidyl-serine phosphorylation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0071361 | Biological process | cellular response to ethanol |
GO_0061744 | Biological process | motor behavior |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0046318 | Biological process | negative regulation of glucosylceramide biosynthetic process |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0038183 | Biological process | bile acid signaling pathway |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_1990044 | Biological process | protein localization to lipid droplet |
GO_0070507 | Biological process | regulation of microtubule cytoskeleton organization |
GO_1903829 | Biological process | positive regulation of protein localization |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0045542 | Biological process | positive regulation of cholesterol biosynthetic process |
GO_1903109 | Biological process | positive regulation of mitochondrial transcription |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_1904179 | Biological process | positive regulation of adipose tissue development |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0055089 | Biological process | fatty acid homeostasis |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0008610 | Biological process | lipid biosynthetic process |
GO_0048643 | Biological process | positive regulation of skeletal muscle tissue development |
GO_1903944 | Biological process | negative regulation of hepatocyte apoptotic process |
GO_0062028 | Biological process | regulation of stress granule assembly |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0120188 | Biological process | regulation of bile acid secretion |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_1903955 | Biological process | positive regulation of protein targeting to mitochondrion |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0043627 | Biological process | response to estrogen |
GO_0019395 | Biological process | fatty acid oxidation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0042593 | Biological process | glucose homeostasis |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0031588 | Cellular component | nucleotide-activated protein kinase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0000785 | Cellular component | chromatin |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0004672 | Molecular function | protein kinase activity |
GO_0004691 | Molecular function | cAMP-dependent protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0047322 | Molecular function | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity |
GO_0140823 | Molecular function | histone H2BS36 kinase activity |
GO_0004679 | Molecular function | AMP-activated protein kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKAA1 |
Protein name | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase (EC 2.7.11.31) (Acetyl-CoA carboxylase kinase) (Hydroxymethylglutaryl-CoA reductase kinase) 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) |
Synonyms | hCG_37338 AMPK1 |
Description | FUNCTION: Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism . In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation . AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators . Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively (By similarity). Promotes lipolysis of lipid droplets by mediating phosphorylation of isoform 1 of CHKA (CHKalpha2) . Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3 (By similarity). AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160 (By similarity). Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A . Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm (By similarity). In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription (By similarity). Acts as a key regulator of cell growth and proliferation by phosphorylating FNIP1, TSC2, RPTOR, WDR24 and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2 . Also phosphorylates and inhibits GATOR2 subunit WDR24 in response to nutrient limitation, leading to suppress glucose-mediated mTORC1 activation . In response to energetic stress, phosphorylates FNIP1, inactivating the non-canonical mTORC1 signaling, thereby promoting nuclear translocation of TFEB and TFE3, and inducing transcription of lysosomal or autophagy genes . In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1 . In that process also activates WDR45/WIPI4 . Phosphorylates CASP6, thereby preventing its autoprocessing and subsequent activation . In response to nutrient limitation, phosphorylates transcription factor FOXO3 promoting FOXO3 mitochondrial import (By similarity). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin . AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it (By similarity). May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it (By similarity). Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo (By similarity). Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1 . Regulates hepatic lipogenesis. Activated via SIRT3, represses sterol regulatory element-binding protein (SREBP) transcriptional activities and ATP-consuming lipogenesis to restore cellular energy balance. . |
Accessions | Q13131 Q96E92 ENST00000397128.7 [Q13131-1] ENST00000296800.4 ENST00000354209.7 [Q13131-2] |